ASPI to Begin Uranium Enrichment at Pelindaba Nuclear Facility

Strategic Insights -

ASPI, a company listed on the Nasdaq exchange and planning a secondary listing on the Johannesburg Stock Exchange (JSE), has entered into an agreement with the South African Nuclear Energy Corporation (Necsa) to collaborate on research, development, and commercial production of advanced nuclear fuels at the Pelindaba nuclear facility. This agreement will enable ASPI to begin uranium enrichment using its proprietary Quantum Enrichment (QE) technology. The company plans to list on the JSE on August 27 and has secured a loan of up to $22 million from TerraPower to partially finance the new uranium enrichment facility.

Key Takeaways:

  • ASPI has entered into an agreement with Necsa to collaborate on research, development, and commercial production of advanced nuclear fuels at the Pelindaba nuclear facility.
  • The agreement will enable ASPI to begin uranium enrichment using its proprietary QE technology.
  • ASPI plans to list on the JSE on August 27 and has secured a loan of up to $22 million from TerraPower to partially finance the new uranium enrichment facility.
  • The initial core supply agreement with TerraPower is valued at up to $375 million over an 18-month timeframe.
  • The 10-year supply agreement for HALEU is valued at up to $3.75 billion, dependent on the quantity of HALEU to be supplied over 10 years and the base price of HALEU.
  • Renergen shareholders have approved a share swap scheme, where each shareholder will receive 0.09196 ASPI shares for each Renergen share held.
  • ASPI's proprietary technologies, Aerodynamic Separation Process and QE technology, are designed to enable the production of isotopes used in several industries.
  • The company's initial focus is the production and commercialization of enriched Carbon-14, Molybdenum-100, and Silicon-28.

Statistics:

  • The initial core supply agreement with TerraPower is valued at up to $375 million over an 18-month timeframe.
  • The 10-year supply agreement for HALEU is valued at up to $3.75 billion, dependent on the quantity of HALEU to be supplied over 10 years and the base price of HALEU.
  • ASPI has secured a loan of up to $22 million from TerraPower to partially finance the new uranium enrichment facility.
  • The market value of ASPI shares is around R15 billion ($831 million).
  • ASPI's share premium account reflected a value of $107.4 million.

Sources:

  • ASPI, Nasdaq listing announcement
  • Necsa, agreement with ASPI
  • TerraPower, loan agreement with ASPI
  • Renergen, shareholder meeting minutes
  • ASPI, pre-listing statement
  • ASPI, press release regarding listing on JSE